SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VPHM - Viropharma Inc
An SI Board Since December 1998
Posts SubjectMarks Bans Symbol
2557 72 0 VPHM
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2332<i>For long-term prophylaxis he recommends 17-alkyalted androgens or anti-Biomaven-9/4/2008
2331NEJM review on HAE. The author is Dr. Zuraw who is receiving consulting fees froidos-9/4/2008
2330JMP Sept 2nd VPHM Update INVESTMENT HIGHLIGHTS · PDUFA date for Berinert pThomas Kirwin-9/3/2008
2329ViroPharma and Lev Receive Hart-Scott-Rodino Clearance from the Federal Trade CoIRWIN JAMES FRANKEL-9/3/2008
2328TheStreet.com - ViroPharma BUY Rating 8/21/08 ViroPharm(VPHM - Cramer's TakThomas Kirwin-8/24/2008
2327As usual Peter is right on. VPHM is getting a great deal on LEVP (I'm long)IRWIN JAMES FRANKEL-8/16/2008
2326<i>Fair value of VPHM is $60+</i> Well yes, if you put stupid numbeBiomaven-8/16/2008
2325Fair value of VPHM is $60+ istockresearch.com Best O'LuckThomas Kirwin-8/16/2008
2324HAE: Biotech's Latest Orphan-Drug Race Elizabeth Trotta <b>07/17/08 Doc Bones-7/24/2008
2323VPHM letter to CDER, important re: Vancocin. viropharma.comIRWIN JAMES FRANKEL-7/21/2008
2322IF the buyout closes, for 6* cents (LEVP at 2.31) you buy: - 50 cents worth of IRWIN JAMES FRANKEL-7/21/2008
2321Yep, in 11.2(b) Target refers to LEVP: ...then Target shall pay to Buyer an amIRWIN JAMES FRANKEL-7/18/2008
2320this may be old news, as I haven't been watching. but termination fee is $1scaram(o)uche-7/18/2008
2319<reply> Romark and Salix.kenhott-7/17/2008
2318<Are you referencing late stage competition to vancocin?> Yes. It looks kenhott-7/17/2008
2317Are you referencing late stage competition to vancocin? vphm is a confusing strkrw-7/16/2008
2316By adding Cinryze, VPHM has made the stock more confusing for a bunch of people kenhott-7/16/2008
2315Everyone knows they were a bidder on Anormed but once genz stepped in, they steprkrw-7/16/2008
2314According to the news feed in Schwab's streetsmart pro (not cut and pastabletom pope-7/16/2008
2313I personally believe that they felt they had to get something done and preferablkenhott-7/16/2008
2312<i>They have a strong cash position even post munch. </i> Well theySteve Lokness-7/15/2008
2311They have a strong cash position even post munch. No doubt working the lines arkrw-7/15/2008
2310<i>Mainly cash which is all worthless anyway :)</i> Ya, unless you Steve Lokness-7/15/2008
2309I don't get the reaction. Mainly cash which is all worthless anyway :) So rkrw-7/15/2008
2308$175m in market cap (non-dilute) goes poof when it's down $2.5.scaram(o)uche-7/15/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News